#Heberprot-P which produces #Cuba benefits #Russia. In #US it is not possible (+ video)

By Alma

The clinical trials for the implementation of the Cuban biopharmaceutical drug Heberprot-P in patients with diabetic foot in Russia show today the effectiveness of the medicine, with prospects of being extended to a larger number of regions.

Sigue leyendo